These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 30233141

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats.
    Chen Y, Gui D, Chen J, He D, Luo Y, Wang N.
    Cell Physiol Biochem; 2014; 33(6):1975-87. PubMed ID: 25012492
    [Abstract] [Full Text] [Related]

  • 4. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L, Fang J, Zhu B, Wang L, Chen J, Wang Y, Huang J, Wang H, Yao X.
    Life Sci; 2021 Mar 15; 269():119068. PubMed ID: 33476631
    [Abstract] [Full Text] [Related]

  • 5. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS, Xiong F, Xie XH, Chen D, Pan JH, Cheng L.
    BMC Nephrol; 2015 Mar 31; 16():44. PubMed ID: 25886386
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation.
    Zhang Y, Tao C, Xuan C, Jiang J, Cao W.
    Oxid Med Cell Longev; 2020 Mar 31; 2020():9542165. PubMed ID: 32855769
    [Abstract] [Full Text] [Related]

  • 10. Astragaloside IV protects against podocyte injury via SERCA2-dependent ER stress reduction and AMPKα-regulated autophagy induction in streptozotocin-induced diabetic nephropathy.
    Guo H, Wang Y, Zhang X, Zang Y, Zhang Y, Wang L, Wang H, Wang Y, Cao A, Peng W.
    Sci Rep; 2017 Jul 31; 7(1):6852. PubMed ID: 28761152
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. LncRNA TUG1 inhibits the proliferation and fibrosis of mesangial cells in diabetic nephropathy via inhibiting the PI3K/AKT pathway.
    Zang XJ, Li L, Du X, Yang B, Mei CL.
    Eur Rev Med Pharmacol Sci; 2019 Sep 31; 23(17):7519-7525. PubMed ID: 31539141
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combination of Ginsenoside Rg1 and Astragaloside IV reduces oxidative stress and inhibits TGF-β1/Smads signaling cascade on renal fibrosis in rats with diabetic nephropathy.
    Du N, Xu Z, Gao M, Liu P, Sun B, Cao X.
    Drug Des Devel Ther; 2018 Sep 31; 12():3517-3524. PubMed ID: 30425453
    [Abstract] [Full Text] [Related]

  • 15. Astragaloside IV improves renal function and fibrosis via inhibition of miR-21-induced podocyte dedifferentiation and mesangial cell activation in diabetic mice.
    Wang X, Gao Y, Tian N, Zou D, Shi Y, Zhang N.
    Drug Des Devel Ther; 2018 Sep 31; 12():2431-2442. PubMed ID: 30122901
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome‑mediated inflammation.
    Feng H, Zhu X, Tang Y, Fu S, Kong B, Liu X.
    Int J Mol Med; 2021 Aug 31; 48(2):. PubMed ID: 34278447
    [Abstract] [Full Text] [Related]

  • 19. Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells.
    Tu Q, Li Y, Jin J, Jiang X, Ren Y, He Q.
    Pharm Biol; 2019 Dec 31; 57(1):778-786. PubMed ID: 31741405
    [Abstract] [Full Text] [Related]

  • 20. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.
    Ma R, Wang Y, Xu Y, Wang R, Wang X, Yu N, Li M, Zhou Y.
    J Diabetes Res; 2021 Dec 31; 2021():8832114. PubMed ID: 34095318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.